Previous studies have focused on the capacity of estrogen to regulate HIF-1α expression in diverse types of cancer cells including thyroid, ovarian, and breast cancer cells, mainly via the PI3K/AKT signaling cascade [180,183,184]. Here, HIF1A is linked to breast carcinoma.